rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ugur Sahin

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, BioNTech SE.

Every Form 4 they filed

In numbers

Trades disclosed
45
Buys
0
Sells
26
Bought
$0
Sold
$147.9M
Companies
1
Companies where not an officer
0
First trade
3 Sep 2026
Last trade
9 Oct 2026
Last filed
9 Oct 2026

Companies traded

Where they are an officer
BNTX BioNTech SEOfficer, 10% owner · Biotechnology · last 9 Oct 20260 buys · 26 sells

Activity over time

1 Aug – 1 Oct
1801 Aug1 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Oct 2026filed 9 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.5M36,209 at $95.37filing
8 Oct 2026filed 9 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$2.5M27,000 at $92.31filing
7 Oct 2026filed 7 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$2.3M24,000 at $95.86filing
6 Oct 2026filed 6 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$2.0M21,000 at $96.81filing
5 Oct 2026filed 6 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$7.0M72,000 at $97.23filing
2 Oct 2026filed 2 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$1.6M17,000 at $96.72filing
1 Oct 2026filed 2 Oct 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$1.7M17,000 at $97.46filing
30 Sep 2026filed 30 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.1M32,000 at $98.12filing
30 Sep 2026filed 30 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.1M32,000 at $98.12filing
29 Sep 2026filed 30 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.3M34,000 at $98.26filing
29 Sep 2026filed 30 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.3M34,000 at $98.26filing
28 Sep 2026filed 28 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.3M34,000 at $98.47filing
28 Sep 2026filed 28 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.3M34,000 at $98.47filing
25 Sep 2026filed 28 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$2.7M27,000 at $98.69filing
25 Sep 2026filed 28 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$2.7M27,000 at $98.69filing
24 Sep 2026filed 24 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.9M39,000 at $98.99filing
24 Sep 2026filed 24 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.9M39,000 at $98.99filing
23 Sep 2026filed 24 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.0M30,000 at $99.40filing
23 Sep 2026filed 24 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$3.0M30,000 at $99.40filing
22 Sep 2026filed 22 Sep 2026BNTX BioNTech SEBiotechnologySEC FORM 4 Sold$4.6M46,000 at $100.72filing

Sectors

Health Care26

Buys in green, sells in red, by the company’s sector.

Related people

Sierk PoettingChief Operating Officer · Chief Operating Officer at BioNTech SE, filing Form 4 there in the last year
Annemarie HanekampChief Commercial Officer · Chief Commercial Officer at BioNTech SE, filing Form 4 there in the last year
James Timothy Patrick RyanSee remarks. · See remarks. at BioNTech SE, filing Form 4 there in the last year
Kylie JimenezChief People Officer · Chief People Officer at BioNTech SE, filing Form 4 there in the last year
Gomez Ramon ZapataChief Financial Officer · Chief Financial Officer at BioNTech SE, filing Form 4 there in the last year